These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 9287172)
21. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. Iyengar S; Schwartz DH; Hildreth JE J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873 [TBL] [Abstract][Full Text] [Related]
22. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection. Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377 [TBL] [Abstract][Full Text] [Related]
23. Chemokine receptors and human immunodeficiency virus infection. Bieniasz PD; Cullen BR Front Biosci; 1998 Jan; 3():d44-58. PubMed ID: 9407151 [TBL] [Abstract][Full Text] [Related]
24. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592 [TBL] [Abstract][Full Text] [Related]
25. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Liu QH; Williams DA; McManus C; Baribaud F; Doms RW; Schols D; De Clercq E; Kotlikoff MI; Collman RG; Freedman BD Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4832-7. PubMed ID: 10758170 [TBL] [Abstract][Full Text] [Related]
27. Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. Lee C; Liu QH; Tomkowicz B; Yi Y; Freedman BD; Collman RG J Leukoc Biol; 2003 Nov; 74(5):676-82. PubMed ID: 12960231 [TBL] [Abstract][Full Text] [Related]
28. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692 [TBL] [Abstract][Full Text] [Related]
29. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Chen Z; Gettie A; Ho DD; Marx PA Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999 [TBL] [Abstract][Full Text] [Related]
30. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Yao Q; Compans RW; Chen C Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813 [TBL] [Abstract][Full Text] [Related]
31. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565 [TBL] [Abstract][Full Text] [Related]
32. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes. Verani A; Sironi F; Siccardi AG; Lusso P; Vercelli D J Immunol; 2002 Jun; 168(12):6388-95. PubMed ID: 12055257 [TBL] [Abstract][Full Text] [Related]
34. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression. LaBonte JA; Madani N; Sodroski J J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984 [TBL] [Abstract][Full Text] [Related]
35. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Xiao X; Kinter A; Broder CC; Dimitrov DS Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381 [TBL] [Abstract][Full Text] [Related]
36. Identification of a major co-receptor for primary isolates of HIV-1. Deng H; Liu R; Ellmeier W; Choe S; Unutmaz D; Burkhart M; Di Marzio P; Marmon S; Sutton RE; Hill CM; Davis CB; Peiper SC; Schall TJ; Littman DR; Landau NR Nature; 1996 Jun; 381(6584):661-6. PubMed ID: 8649511 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415 [TBL] [Abstract][Full Text] [Related]
38. [Originality of entry inhibitors]. Izopet J Med Mal Infect; 2009 Oct; 39(10 Suppl 1):H1-4. PubMed ID: 19837343 [No Abstract] [Full Text] [Related]
39. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248 [TBL] [Abstract][Full Text] [Related]